北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (5): 819-823. doi: 10.3969/j.issn.1671-167X.2017.05.013

• 论著 • 上一篇    下一篇

类风湿关节炎患者髓系来源的抑制细胞促进自身B细胞增殖

陈玮1, 2, 胡凡磊1, 刘洪江1, 徐丽玲1, 李英妮1, 栗占国1   

  1. 1. 北京大学人民医院风湿免疫科,风湿病机制及免疫诊断北京市重点实验室,北京 100044;
    2.成都医学院免疫学教研室,成都 610500
  • 收稿日期:2015-12-23 出版日期:2017-10-18 发布日期:2017-10-18
  • 基金资助:
    国家自然科学基金(81671604、81302554、81401341)资助

Myeloid-derived suppressor cells promoted autologous B cell proliferation in rheumatoid arthritis

CHEN Wei1, 2, HU Fan-lei1, LIU Hong-jiang1, XU Li-ling1, LI Ying-ni1, LI Zhan-guo1   

  1. 1. Department of Rheumatology and Immunology, Peking University People’s Hospital &
    Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis, Beijing 100044, China;
    2.Department of Immunology, Chengdu Medical College, Chengdu 610500, China
  • Received:2015-12-23 Online:2017-10-18 Published:2017-10-18
  • Supported by:
    Supported by the National Natural Science Foundation of China (81671604, 81302554,81401341)

摘要: 目的 探讨类风湿关节炎(rheumatoid arthritis,RA)患者髓系来源的抑制细胞(myeloid-derived suppressor cells,MDSC)对自身B细胞增殖的影响,揭示MDSC在RA发病中的作用。方法 健康对照15例,RA患者38例,按28-关节疾病活动度分值(28-joint disease activity score,DAS28)分为高疾病活动度组(DAS28>5.1)、中疾病活动度组(3.2<DAS28≤5.1)和低疾病活动度组(2.6<DAS28≤3.2), 流式细胞术检测其外周血MDSC细胞的比例;同时分选10例高疾病活动度RA患者外周血B细胞和MDSC细胞体外共培养,羟基荧光素二醋酸盐琥珀酰亚胺酯(carboxyfluorescein diacetate succinimidyl ester,CFSE)法检测B细胞的增殖。结果 高疾病活动度RA外周血MDSC比例(7.13%±2.17%)相对于健康成年人(4.79%±1.02%)、中活动度患者(5.35%±1.36%)和低活动度患者(4.72%±1.08%)明显增加(P<0.05),而中、低疾病活动度RA之间及其二者与健康成年人之间差异皆无统计学意义(P>0.05);MDSC比例与患者DAS28分值成正相关(P<0.05),与年龄、病程、类风湿因子(rheumatoid factor,RF)、抗环瓜氨酸多肽(cyclic citrullinated peptide,CCP)抗体等无相关性;MDSC共培养不抑制反而促进B细胞的增殖(P<0.01)。结论 MDSC在高疾病活动度RA患者外周血中明显增加,与疾病活动度呈正相关,并可在体外促进自身B细胞的增殖,提示MDSC可能通过调节B细胞的功能参与RA的疾病进程。

关键词: 髓系来源的抑制细胞, 关节炎, 类风湿, B淋巴细胞, 细胞增殖

Abstract: Objective: To investigate the effect of myeloid-derived suppressor cells (MDSC) on pro-liferation of B lymphocytes in rheumatoid arthritis (RA) patients. Methods: The peripheral blood specimens were collected from 15 healthy adults and 38 RA patients who were divided into high disease activity group, medium activity group and low activity group according to their 28-joint disease activity score (DAS28). And the frequencies of MDSC were determined by flow cytometry. Then, B cells and MDSC were isolated by flow cytometry, respectively. B cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) and then were co-cultured with MDSC in the presence of 3 mg/L anti-CD40 antibody and 10 mg/L CpG, for 3 days. Flow cytometry was performed to investigate the proliferation of B cells. Results: MDSC expanded markedly in high disease activity patients (7.13%±2.17%) compared with medium (5.35%±1.36%) and low disease activity patients (4.72%±1.08%) or healthy controls (4.79%±1.02%) (P<0.05), and there were no statistical differences between healthy controls, medium and low disease activity RA (P>0.05). Moreover, the frequencies of MDSC were positively correlated with the DAS28 (P<0.05). After co-culture, MDSC significantly promoted B cell proliferation (P<0.01). Conclusion: Our studies showed that MDSC expanded obviously in high disease activity RA patients, and their frequencies were positively correlated with the disease activities. Furthermore, MDSC could promote autologous B cell proliferation remarkably in vitro. These findings suggest that MDSC might be involved in RA pathogenesis through regulating B cell functions.

Key words: Myeloid-derived suppressor cells, Arthritis, rheumatoid, B-lymphocytes, Cell proliferation

中图分类号: 

  • R593.22
[1] Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis [J]. Cell, 1996, 85(3): 307-310.
[2] Bax M, Huizinga TW, Toes RE. The pathogenic potential of autoreactive antibodies in rheumatoid arthritis [J]. Semin Immunopathol, 2014, 36(3): 313-325.
[3] Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system [J]. Nat Rev Immunol, 2009, 9(3): 162-174.
[4] Marigo I, Dolcetti L, Serafini P, et al. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells [J]. Immunol Rev, 2008(222): 162-179.
[5] Crook KR, Liu P. Role of myeloid-derived suppressor cells in autoimmune disease [J]. World J Immunol, 2014, 4(1): 26-33.
[6] Guo C, Hu F, Yi H, et al. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis [J]. Ann Rheum Dis, 2016, 75(1): 278-285.
[7] Edwards JC, Szczepanski L, Szechinski J, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J]. N Engl J Med, 2004, 350(25): 2572-2581.
[8] Young MR, Newby M, Wepsic TH. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors [J]. Cancer Res, 1987, 47(1): 100-106.
[9] 许为民, 龚爱华, 王慧, 等. 类风湿关节炎患者外周血髓系来源的抑制细胞的检测及与Th1/Th2细胞的相关性分析[J]. 江苏大学学报(医学版), 2013, 23(2): 140-143.
[10] Li Y, Tu Z, Qian S, et al. Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis [J]. J Immunol, 2014, 193(5): 2127-2134.
[11] Crook KR, Jin M,Weeks MF, et al. Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease [J]. J Leukoc Biol, 2015, 97(3): 573-582.
[1] 宋志博,耿研,邓雪蓉,张晓慧,张卓莉. 肌肉骨骼超声在指导银屑病关节炎临床分型中的价值[J]. 北京大学学报(医学版), 2021, 53(6): 1061-1066.
[2] 张璐,胡小红,陈澄,蔡月明,王庆文,赵金霞. 类风湿关节炎初治患者颈椎失稳情况及临床特征[J]. 北京大学学报(医学版), 2021, 53(6): 1049-1054.
[3] 邓雪蓉,孙晓莹,张卓莉. 类风湿关节炎患者足踝部体征和超声下病变的一致性[J]. 北京大学学报(医学版), 2021, 53(6): 1037-1042.
[4] 罗靓,霍文岗,张钦,李春. 类风湿关节炎合并角膜溃疡的临床特点和相关因素分析[J]. 北京大学学报(医学版), 2021, 53(6): 1032-1036.
[5] 钟华,徐丽玲,白明欣,苏茵. 类风湿关节炎患者趋化因子CXCL9和CXCL10在骨侵蚀中的作用[J]. 北京大学学报(医学版), 2021, 53(6): 1026-1031.
[6] 娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健. 类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达[J]. 北京大学学报(医学版), 2021, 53(6): 1020-1025.
[7] 李正芳,吴雪,武丽君,罗采南,石亚妹,钟岩,陈晓梅,孟新艳. Rhupus综合征的临床特点[J]. 北京大学学报(医学版), 2021, 53(5): 933-937.
[8] 王贵红,左婷,李然,左正才. 瑞巴派特在大鼠痛风性关节炎急性发作中的作用[J]. 北京大学学报(医学版), 2021, 53(4): 716-720.
[9] 马向波,张学武,贾汝琳,高颖,刘洪江,刘玉芳,李英妮. 外周血淋巴细胞亚群检测在系统性硬化症治疗中的应用[J]. 北京大学学报(医学版), 2021, 53(4): 721-727.
[10] 吴俊慧,陈泓伯,武轶群,吴瑶,王紫荆,吴涛,王梦莹,王斯悦,王小文,王伽婷,于欢,胡永华. 2015—2017年北京市2型糖尿病患者骨关节炎患病的相关因素[J]. 北京大学学报(医学版), 2021, 53(3): 518-522.
[11] 赵凯,常志芳,王志华,庞春艳,王永福. 基因沉默肽基精氨酸脱亚胺酶4的表达对胶原诱导关节炎小鼠肺间质病变的影响[J]. 北京大学学报(医学版), 2021, 53(2): 235-239.
[12] 曹迪,王燕,王柳青,孙晓麟,黄妃,孟洋,任丽丽,张学武. 血浆Dickkopf-1在类风湿关节炎患者中的表达及其与外周血T细胞亚群的相关性[J]. 北京大学学报(医学版), 2021, 53(2): 255-260.
[13] 柯岩,张蔷,马云青,李儒军,陶可,桂先革,李克鹏,张洪,林剑浩. 全髋关节置换术治疗脊柱骨骺发育不良患者Tönnis 3级髋关节骨关节炎的早期疗效[J]. 北京大学学报(医学版), 2021, 53(1): 175-182.
[14] 钟剑球,曾沛英,王庆文. 类风湿关节炎合并淋巴水肿2例及文献回顾[J]. 北京大学学报(医学版), 2020, 52(6): 1157-1161.
[15] 魏士雄,黎苏佳,刘毅. 幼年特发性关节炎成人后的临床特点及生物制剂治疗[J]. 北京大学学报(医学版), 2020, 52(6): 1014-1022.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 张三. 中文标题测试[J]. 北京大学学报(医学版), 2010, 42(1): 1 -10 .
[2] 赵磊, 王天龙 . 右心室舒张末期容量监测用于肝移植术中容量管理的临床研究[J]. 北京大学学报(医学版), 2009, 41(2): 188 -191 .
[3] 万有, , 韩济生, John E. Pintar. 孤啡肽基因敲除小鼠电针镇痛作用增强[J]. 北京大学学报(医学版), 2009, 41(3): 376 -379 .
[4] 张燕, 韩志慧, 钟延丰, 王盛兰, 李玲玲, 郑丹枫. 骨骼肌活组织检查病理诊断技术的改进及应用[J]. 北京大学学报(医学版), 2009, 41(4): 459 -462 .
[5] 赵奇, 薛世华, 刘志勇, 吴凌云. 同向施压测定自酸蚀与全酸蚀粘接系统粘接强度[J]. 北京大学学报(医学版), 2010, 42(1): 82 -84 .
[6] 林红, 王玉凤, 吴野平. 学校生活技能教育对小学三年级学生行为问题影响的对照研究[J]. 北京大学学报(医学版), 2007, 39(3): 319 -322 .
[7] 丰雷, 程嘉, 王玉凤. 注意缺陷多动障碍儿童的运动协调功能[J]. 北京大学学报(医学版), 2007, 39(3): 333 -336 .
[8] 李岳玲, 钱秋瑾, 王玉凤. 儿童注意缺陷多动障碍成人期预后及其预测因素[J]. 北京大学学报(医学版), 2007, 39(3): 337 -340 .
[9] . 书讯[J]. 北京大学学报(医学版), 2007, 39(3): 225 -328 .
[10] 牟向东, 王广发, 刁小莉, 阙呈立. 肺黏膜相关淋巴组织型边缘区B细胞淋巴瘤一例[J]. 北京大学学报(医学版), 2007, 39(4): 346 -350 .